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ABSTRACT 
During the process of phagocytosis, polymorphonuclear leukocytes (PMN) release 
lysosomal  enzymes  into  the  extracellular  medium.  When  the  antibiotic  cyto- 
chalasin  B  (CB)  is  present  in  the  incubation  medium  along  with  phagocytable 
particles, enhanced recovery of enzyme activities from the incubation medium has 
been  observed.  These  findings  have  led  to  the  interpretation  that  CB  enhances 
lysosomal enzyme release. Our results contradict this interpretation. The lysoso- 
mal  enzymes acid  phosphatase  and  /3-galactosidase  are  unstable  after they  are 
released from cells. During the first 5-15 min of phagocytosis, significant amounts 
of  both  acid  phosphatase  and  /3-galactosidase  can  be  recovered  from  the 
extracellular  medium.  After  this,  the  recovery  of  enzyme  from  the  medium 
declines, presumably because the rate of loss of lysosomal enzyme activity exceeds 
the rate of release at later time periods.  In the presence of CB, the appearance of 
lysosomal enzymes in  the  extracellular  medium  of cells  exposed  to  zymosan is 
retarded for 5-l0 rain, after which it begins and then continues for approximately 
20 min. At the end of a 30-rain incubation period, therefore, in the absence of CB, 
extracellular levels of lysosomal enzymes (especially those which are unstable) are 
declining toward low levels while, in the presence of CB, extracellular enzyme levels 
are continuing to rise. We also measured the lysosomal enzyme remaining within 
cells after exposure to zymosan. CB retarded the disappearance of enzyme from 
cells and resulted in significantly less total cell enzyme loss. Thus, in the presence of 
CB, a greater proportion of the lysosomal enzyme lost from cells is recovered in the 
extracellular medium.  In  contrast to the previous conclusions that  CB enhances 
lysosomal enzyme release,  our results  indicate that CB delays and decreases the 
zymosan-stimulated release of lysosomal enzymes from PMN.  Since CB inhibits 
phagocytosis  by  PMN,  our  results  indicate  that  the  antibiotic  modifies  the 
mechanism  of release of lysosomal enzymes, resulting in zymosan stimulation of 
their release independently of phagocytosis. 
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Lysosomal  enzymes  are  released  from  polymor- 
phonuclear leukocytes (PMN) 1 when the cells are 
stimulated  in  any  of several  ways.  Reports  from 
several  laboratories  have  indicated  that  the 
amounts of lysosomal enzyme recovered from the 
incubation  medium  of  cells  stimulated  for  pro- 
longed periods  are increased when cytochalasin B 
(CB)  is  also  present.  CB  enhances  the  recovery 
from  extracellular medium  of lysosomal enzymes 
released from rabbit PMN  exposed to Escherichia 
coli (1), from rabbit and human PMN  adherent to 
immune complexes attached to surfaces too large 
to be phagocytosed (2), from rabbit PMN  exposed 
to latex particles coated with rabbit gamma globu- 
lin (3), and from human PMN exposed to zymosan 
particles  (4,  5)  or  immune  complexes  on  a  non- 
phagocytable Millipore filter (4).  These effects of 
CB on lysosomal enzyme release occur in spite of 
inhibition of phagocytosis and of increased carbo- 
hydrate  metabolism  associated  with  particle  up- 
take by PMN. The experiments reported here were 
done to characterize the effect of CB on lysosomal 
enzyme release and elucidate the mechanism of the 
effect of the antibiotic. 
MATERIALS  AND  METHODS 
Zymosan  (Sigma  Chemical  Co.,  St.  Louis,  Mo.)  was 
suspended  in  saline  and  boiled.  The  suspension  was 
cooled to 37°C, and an equal volume of plasma from the 
donor of cells used in the experiment was added. After 
the  mixture  had  been  incubated  at  37°C  for  1 h,  the 
zymosan was  collected  by centrifugation, washed twice 
with  Krebs-Ringer  phosphate  (KRP)  buffer  (6)~ and 
suspended in the buffer for incubation. A stock solution 
(1  mg/ml)  of CB  (Imperial  Chemical  Industries) was 
prepared in dimethylsulfoxide and diluted with buffer to 
give the desired experimental concentrations. [Carboxyl- 
~4C]inulin was purchased from Amersham/Searle Corp. 
(Arlington  Heights,  Ill.).  Trace  amounts  (0.5  /~Ci/0.5 
ml) were used in the incubation mixtures. 
Human  peripheral  blood  leukocytes  were  isolated 
from normal male donors. 1 vol of 6% dextran was added 
to 5 vol of heparinized blood to facilitate sedimentation 
of  erythrocytes.  The  plasma  was  removed  and  cen- 
trifuged at 250 g for 10 min. The white cell pellet which 
was  obtained  was  suspended  in  10  ml  of  plasma  and 
mixed  with  30  ml  of  0.87%  NH4C1  to  lyse  residual 
erythrocytes (7). The mixture was centrifuged, and white 
cells were washed twice in KRP buffer containing 0.01% 
Abbreviations used in this paper: CB,  cytochalasin B; 
KRP,  Krebs-Ringer  phosphate;  LDH,  lactic dehydro- 
genase; PMN, polymorphonuclear leukocytes. 
gelatin, and suspended in buffer before addition of cells 
to incubation tubes. The final suspension contained 1  2 
×  107 cells/0.2 ml (80-95% PMN). 
When cells were preincubated with CB, 0.2 ml of cell 
suspension was added to tubes containing 0.2 ml of CB to 
give the desired final concentration. After preincubation, 
0.1  ml  of  zymosan  suspension  was  added  and  the 
incubation continued. In other experiments, 0.2 ml of cell 
suspension was added to tubes containing 0.3 ml of buffer 
with  the  appropriate  additions.  Glucose,  when  present 
(see figures), was used at a final concentration of 5 mM. 
All incubations were done in triplicate. At the end of the 
desired  incubation  time,  tubes  containing  cells  were 
placed in an ice bath, and 1 ml of KRP buffer containing 
nonradioactive inulin,  I  mg/ml,  was  added.  The  cells 
were  transferred to  5-ml siliconized conical centrifuge 
tubes  with  two  1-ml  washes  of  inulin  in  buffer  and 
centrifuged at 250 g for 10 min. The supernate was saved 
for the determination of enzyme activities, and the cell 
pellet saved  for the determination of either [t4C]inulin 
content or cell-associated enzyme activity. 
The uptake of [~4C]inulin (presumably into phagocytic 
vesicles) served as an index of phagocytosis (5, 8). Inulin 
can  also  enter  cells  in  pinocytic  vesicles.  In  these 
experiments, [~'C]inulin taken up by ceils not exposed to 
zymosan was less than  10% of the amount that entered 
cells incubated with zymosan,  1 mg/ml, for 30 rain. 
In  studies  of  the  effects  of CB  on  the  stability  of 
lysosomal enzymes, cells were incubated with zymosan (3 
mg/ml) for  10 rain in the absence of CB or for 20 min 
with CB (10 gg/ml). Cells were separated from incuba- 
tion medium  by centrifugation. 0.5-ml aliquots  of me- 
dium  were  pipetted  into  tubes  containing  0.01  ml  of 
either KRP buffer or buffer containing CB (final concen- 
tration 40 #g/ml) and incubated for 20, 40, or 60 min. In 
a  similar  experiment,  cells  were  first  incubated  with 
zymosan (1 mg/ml) for 30 min and then separated from 
medium by centrifugation. The cell pellet was suspended 
in  KRP  buffer  containing  0.2%  Triton  and  lysed  by 
sonication. The lysate was then diluted with buffer to give 
enzyme  activities  similar  to  those  in  the  incubation 
medium from which cells had been removed. Aliquots of 
medium or diluted cell lysate were incubated as before, 
either with or without CB (20 #g/ml) for up to 90 min. 
Incubations were  stopped  by  the  addition  of 6  vol  of 
chilled buffer. The contents of the incubation tubes were 
frozen,  stored,  and thawed  at  a  later time for enzyme 
assays. 
The  activity  of  fl-glucuronidase  was  measured  as 
previously described (7),  using phenolphthalein glucuro- 
hide as substrate.  For acid phosphatase determinations, 
p-nitrophenyl-phosphate  served  as  substrate,  and  for 
~-galactosidase  determinations  p-nitrophenyl-galacto- 
side was used.  Measurements of lactic dehydrogenase in 
extracellular medium (9) showed that less than 2% of the 
total activity of that enzyme was released in all experi- 
ments,  indicating  negligible  cell  death  (10).  For  all 
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measured on tubes removed at zero time were subtracted 
from  other  values.  Total  enzyme  activity  and  cell- 
associated enzyme activity were determined in cell sus- 
pensions lysed by Triton X-100 (10). 
RESULTS 
In  order to explore the specificity  of the effect of 
CB  upon  zymosan-stimulated  lysosomal  enzyme 
release, we measured the effect of the antibiotic on 
the  release  of  fl-glucuronidase,  /3-galactosidase, 
and  acid  phosphatase.  In  a  series  of preliminary 
experiments,  cells  obtained  from  17  different  do- 
nors  were  incubated  on  20  occasions  either  in 
buffer  alone  or  in  the  presence  of  zymosan,  I 
mg/ml  (Fig.  i).  Enzyme  activity  in  the  medium 
was determined after 30 min of incubation. Signifi- 
cantly greater amounts of all three enzymes were 
recovered from the medium  when cells were incu- 
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Recovery of lysosomal enzyme activity from 
incubation medium of PMN exposed to zymosan. PMN 
were isolated from the blood of 17 normal human donors 
on 20 occasions and incubated for 30 min oither in buffer 
alone (clear bars) or with zymosan,  1 mg/ml (stippled 
bars), as described in Materials and Methods. At the end 
of 30-rain incubation, cells were separated from incuba- 
tion  medium  which  was  saved  for  determination  of 
enzyme activities. The height of each bar represents the 
mean  of  20  experiments.  The  lengths  of  the  lines 
represent two standard errors of the means. The signifi- 
cance (Student's t test) of the differences between groups 
is indicated. 
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FIGURE  2  Effect of preincubation with CB on phagocy- 
tosis and  recovery of lysosomal enzymes in  incubation 
medium.  Cells were preincubated for 30 min in a  total 
volume of 0.4 ml without or with CB at the concentration 
indicated. Zymosan, 0. l ml (O, to give a final concentra- 
tion of 1 mg/ml), or buffer, 0.1  ml (O), was added and 
incubation continued  for  an  additional 30  min.  Inulin 
uptake  and  activities  of  lysosomal  enzymes  in  the 
incubation medium were measured as described in Mate- 
rials and Methods. 
bated with zymosan.  However, whereas an average 
of  8.9%  of the total  cellular fl-glucuronidase  was 
recovered in the incubation medium, only 3.6%  of 
fl-galactosidase and 4.6% of acid phosphatase were 
recovered.  To  test  the  effect  of  CB,  cells  were 
preincubated  with  the  antibiotic for  30  min,  and 
[l~C]inulin  in  either  buffer  or  buffer  containing 
zymosan  was  then  added  (Fig.  2).  After an  addi- 
tional  30  min  of incubation,  enzyme  activities in 
the  medium  were  measured  and  cells  were  pre- 
pared  for  analysis  of  [l~C]inulin.  Cells  preincfi- 
bated  with  CB  took  up  less  inulin  than  control 
cells,  reflecting  the  inhibition  of phagocytosis  by 
the antibiotic (l l,  12). Only negligible amounts of 
fl-galactosidase  and  acid  phosphatase  were  re- 
covered  from  the  medium  when  cells  were  incu- 
bated  with  zymosan  alone.  However,  when  cells 
were  incubated with both zymosan  and CB,  6-60 
#g/ml,  the recovery  of activities of these enzymes 
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cells incubated with zymosan alone. Preincubation 
of cells with CB had a negligible influence on the 
recovery of #-glucuronidase from cells incubated 
with zymosan, except at the highest concentration 
tested,  200  ~g/ml,  where  recovery  of  all  three 
lysosomal enzymes declined. 
CB  inhibits the  uptake  of glucose  by  human 
PMN  (13).  We  previously  suggested  that  the 
effects of the antibiotic on phagocytosis and lyso- 
somal  enzyme  release  were  not  coupled  to  this 
effect on glucose metabolism, since phagocytosis 
and ~/-glucuronidase released in response to zymo- 
san  were  not altered  by the  omission of glucose 
from  the  medium (5).  The data  shown in Fig.  3 
confirm and extend this observation. Glucose had 
no effect upon [~'C]inulin uptake by cells preincu- 
bated  with  CB  and  then  exposed  to  zymosan. 
Likewise, incubation of cells with glucose did not 
alter the  recoveries from the medium of #-galac- 
tosidase,  acid  phosphatase,  and  ~/-glucuronidase 
activities. 
It  has  been  suggested  that  CB  augments  the 
release  of  lysosomal  enzymes  by  removing  a 
barrier  to  their  release  (1,  2,  4).  The  antibiotic 
might,  therefore,  enhance the  rate  of  release  of 
lysosomal enzymes from cells exposed to zymosan. 
To test this possibility, we preincubated cells for 30 
min in the absence or presence of CB,  20 #g/ml 
(Fig. 4).  Zymosan, in an amount to give  a  final 
concentration of 1 mg/ml, was then added. Incu- 
bations were stopped at varying times up to 30 min 
after the addition of zymosan. During the preincu- 
bation period there was a small release of lysoso- 
mal enzyme activity, which  was inhibited by CB. 
After  exposure  to  zymosan,  acid  phosphatase, 
#-galactosidase,  and  #-glucuronidase  activities 
promptly appeared  in the  medium. #-Glucuroni- 
dase continued to appear for 20 rain at which time 
extracellular levels  reached  a  plateau. The activi- 
ties of acid phosphatase and ~-galactosidase in the 
medium reached maxima at 5 min after exposure 
to zymosan. The activities of both enzymes in the 
medium then declined. The release of each lysoso- 
mal enzyme activity from cells preincubated with 
CB  was  retarded  for  5  min  after  exposure  to 
zymosan. After this lag period, the enzymes were 
released during the remainder of the 30-rain incu- 
bation. The uptake of [~4C]inulin was inhibited in 
cells  preincubated  with  CB,  as  expected  from 
previous studies. 
The data shown in Fig. 4 suggest that CB does 
not enhance the release of lysosomal enzymes, but 
rather  retards  their  release  for  a  period  of time 
after exposure of cells to zymosan. This interpreta- 
tion is complicated, however, by the observations 
that  small  amounts  of lysosomal enzymes were 
released during the period of preincubation with- 
out  zymosan and that  CB  inhibited this  release. 
Therefore,  we  measured  the  time-course  of  the 
effect of CB without preincubation (Fig. 5). In the 
presence of zymosan alone, the activities of acid 
phosphatase  and ~-galactosidase increased in the 
medium in the  first  15  min of incubation, after 
which  they  declined  slightly.  In  the  presence  of 
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The  effects of  glucose and  preincubation 
with CB on phagocytosis and the recovery of lysosomal 
enzymes from medium of PMN  exposed to  zymosan. 
Cells  were preincubated with CB  for  30  rain  at  the 
concentrations indicated. A suspension of zymosan, 0.1 
ml (to give a final concentration of  I mg/ml),  and of 
glucose, either 0 (©) or 5 mM (O), was then added. At 
the  end  of  an  additional  30-min incubation  period, 
lysosomal enzyme activity in  medium and  [~'C]inulin 
uptake by cells were measured as described in Materials 
and Methods. For reference, values from cells incubated 
without zymosan or  CB  and with (11) or  without (Fq) 
glucose during the final 30 min are indicated. 
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FIGURE  4  Time-course of recovery of lysosomal enzymes in incubation medium, and of phagocytosis by 
cells exposed to zymosan after preincubation with CB. Cells were incubated in a total volume of 0.4 ml in 
the presence (0) or absence (O) of CB, 20 #g/ml. After 30 min, 0.1 ml of zymosan (to give a final concen- 
tration of 1 mg/ml) was added to each tube (arrow) and incubation continued for an additional 30 min. 
Tubes were  removed at intervals, and measurements of inulin uptake and lysosomal enzyme activity in 
medium were done as described in Materials and Methods. 
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FIGURE  5  Time-course of the effect of CB on phagocytosis and on recovery of lysosomal enzymes and 
LDH  from incubation medium  on exposure of cells to zymosan. The incubation medium contained: no 
addition (F-I); zymosan, 1 mg/ml (0); zymosan plus CB, 3 #g/ml (I) or 30 #g/ml (a). Tubes were removed 
at intervals during the incubation for measurement of lysosomal enzymes in incubation medium and uptake 
of ['4C]inulin into cells,  as described in Materials and Methods. 
zymosan and 30 tzg/ml of CB, the release of these 
enzymes was initially retarded. The medium activi- 
ties  then  rose  and  continued  to  rise  for  the 
remainder of the incubation period. The curves of 
enzyme  activity  in  the  medium  vs.  time  for  cells 
incubated  with  zymosan  and  CB,  3  ug/ml,  were 
intermediate between those described above. In the 
presence of zymosan alone, ~-glucuronidase activ- 
ity in the medium increased for the first 20 min of 
incubation  and  then  reached  a  plateau.  CB,  30 
/zg/ml,  again  initially  retarded  the  zymosan- 
stimulated  increase  in  medium  enzyme  activity. 
The extracellular enzyme activity then rose and, by 
the  end  of  the  30-min  period,  reached  a  level 
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san  alone.  Again,  cells  incubated with  zymosan 
and CB, 3 ~tg/ml, released 13-glucuronidase activity 
with an intermediate time-course. Cells incubated 
with  neither  zymosan  nor  CB  were  shown,  as 
previously, to release only small amounts of lyso- 
somal enzymes during a 30-min incubation period. 
No significant amounts of the cytoplasmic enzyme 
lactic dehydrogenase (LDH) were  released under 
any  conditions of  incubation. Phagocytosis  was 
inhibited by CB, as demonstrated previously. 
Lysosomal acid phosphatase (a-naphthyl-phos- 
phate phosphatase) has been shown to be labile in 
solution after release into the incubation medium 
(14).  Our  results  suggest  that O-galactosidase as 
well  as  acid  phosphatase  (measured  using  p- 
nitrophenyl-phosphate as  substrate)  is  similarly 
unstable (Figs. 4 and 5). The effects of CB noted 
above could have resulted from an inhibitory effect 
of the antibiotic on the decay of lysosomal enzyme 
activities in extracellular fluid. Results of a series 
of experiments indicate that CB does not, however, 
stabilize lysosomal enzymes.  Lysosomal enzyme 
activities were  released from cells incubated with 
zymosan or with zymosan plus CB (Fig. 6). Cells 
were  removed  by  centrifugation.  Medium  re- 
covered from cells incubated with zymosan alone 
was  divided,  and  incubated  in  the  presence  or 
absence  of  CB.  Medium  obtained  from  cells 
exposed to both zymosan and CB was incubated in 
the  continued  presence  of  CB.  The  activity  of 
/3-glucuronidase was stable for up to 60 min under 
all conditions tested.  The activities of acid phos- 
phatase  and  /3-galactosidase  declined with  time. 
CB  did  not  retard  the  rate  of  loss  of enzyme 
activity. In fact, acid phosphatase and/3-galactosi- 
dase activities released from cells in the presence of 
CB appeared to decay at a  faster rate than when 
they  were  released  in  the  presence  of  zymosan 
alone. 
In another experiment (Fig. 7), cells were  incu- 
bated  with  zymosan (1  mg/ml) for  30  rain, and 
then  separated  from  medium  by  centrifugation. 
The medium was then incubated as before, with or 
without CB. The cell pellet was sonicated, diluted, 
and incubated with or without CB.  B-Glucuroni- 
dase was the most stable of the enzyme activities in 
the cell lysate preparation, followed by acid phos- 
phatase,  then  t3-galactosidase.  Likewise,  in  the 
preparation obtained from the supernate, the sta- 
bility of 13-glucuronidase  far exceeded  that of the 
other two enzymes. CB did not significantly alter 
the  stability  of  any  of  the  enzymes  in  either 
preparation. 
The experiments cited thus far indicated that CB 
does not, as previously suggested, enhance the rate 
of release of lysosomal enzymes from cells exposed 
to  particles,  but  rather  retards  enzyme  release. 
They  also  indicated  that  CB  does  not  alter  the 
stability of lysosomal enzymes after their release 
into the  medium.  It  has  been demonstrated that 
release of lysosomal enzymes from phagocytosing 
cells is associated with a decrease in the amount of 
cell-associated  enzyme  (14).  To  elucidate  the 
mechanism of action of CB further, we incubated 
cells in the presence of zymosan with or without 
added  antibiotic (Fig.  8).  After varying times of 
incubation, cells and  medium were  separated  by 
centrifugation  and  enzyme  activity  in  the  two 
fractions determined. Cell-associated activities of 
both  13-galactosidase  and  13-glucuronidase  fell 
promptly when cells were exposed to zymosan and 
they continued to  fall for approximately 30  min. 
Cell-associated  enzyme  activity  was  lost  more 
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FIGURE 6  Effect of CB on stability of lysosomal en- 
zymes released from cells. Cells were incubated with 
zymosan and then separated from the incubation me- 
dium  which was  divided into  aliquots  and  incubated 
without (open symbols) or with (half-closed symbols) CB 
(40 tzg/ml). Cells were also incubated in the presence of 
zymosan plus CB (10 #g/ml) and separated from the 
medium. Aliquots of this medium were then incubated 
(closed symbols, dashed lines). Incubation of medium 
rich in lysosomal enzymes was stopped by freezing the 
tubes which were then stored for assay, after thawing, of 
/3-glucuronidase (©), acid phosphatase (I-I), and/3-galac- 
tosidase (A) activities. 
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FIGURE 7  Effect of CB on stability of lysosomal enzymes released  from cells by stimulation with zymosan 
and  by  sonication.  Cells were incubated  with  zymosan  (1  mg/ml) for 30 rain  and then  separated  from 
incubation medium by centrifugation. The cell pellet was lysed by freeze-thawing in the presence  of Triton, 
and  the lysate was diluted.  Aliquots of incubation  medium  and  of cell lysate, rich  in lysosomal enzyme 
activities, were incubated for periods of time up to 90 min in the absence (open symbols) or presence (closed 
symbols)  of CB (20 u.g/ml).  At the end of the appropriate incubation period, the contents of the tubes were 
frozen and later thawed and assayed  for/3-glucuronidase (O), acid phosphatase  (r--I), and/3-galactosidase 
(A) activities. 
slowly  from  cells  exposed  to  both  zymosan  and 
CB, and the extent of loss was less than that from 
cells exposed to zymosan alone. The effects of CB 
on  recovery of lysosomal enzyme activities in  the 
medium  were similar to those described  in earlier 
experiments. 
DISCUSSION 
It has been amply demonstrated that PMN under- 
going  phagocytosis  in  vitro release  lysosomal  en- 
zymes  into  the  incubation  medium  (1  5,  10,  14). 
However, when cells are incubated with the antibi- 
otic CB,  which  inhibits  phagocytosis,  the  activity 
of  lysosomal  enzymes  recovered  in  the  medium 
after  30-60  min  of  exposure  to  phagocytable 
particles  equals  or  exceeds  that  recovered  in  the 
medium  of  cells  incubated  with  zymosan  alone 
(1-5).  Thus,  phagocytosis  is  not  required  for 
enzyme  release.  These  findings  have  also  been 
interpreted as indicating that CB enhances the rate 
of release  of lysosomal  enzymes.  This interpreta- 
tion  is open  to question,  however,  since  measure- 
ments of enzyme activities in extracellular medium 
were made at only one time point after exposure to 
phagocytable particles. 
Wright  and  Malawista  (14)  observed  that  the 
activities of some lysosomal enzymes  (acid  phos- 
phatase  and  cathepsin)  increased  only  slightly  in 
the incubation  medium when PMN  ingested heat- 
killed bacteria. The fall in cell-associated activities 
of these enzymes was significant and  far exceeded 
the  enzyme  activity  which  appeared  in  the  me- 
dium. These findings were explained by the further 
observations  that  acid phosphatase  and  cathepsin 
activities  were  unstable  when  preparations  con- 
taining  these enzymes were  incubated  in extracel- 
lular  medium.  We  have  similarly  observed  that 
only  relatively  small  amounts  of  the  lysosomal 
enzyme  (3-galactosidase  can  be  recovered  from 
extracellular  medium  30  min  after  exposure  of 
PMN  to  zymosan.  This  finding  can  also  be 
attributed  to  instability  of the enzyme  activity in 
incubation  medium.  Significant acid  phosphatase 
and/3-galactosidase  activities were recovered from 
the  medium,  however,  when  cells  were  preincu- 
bated  with  CB  before exposure  to  zymosan.  One 
possible  explanation  for this finding is that  CB in 
some way stabilized the enzymes released into the 
extracellular medium.  It was not possible to dem- 
onstrate, however, that the stabilities of either acid 
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FIGURE 8  Time-course of influence of CB on recovery of lysosomal enzymes from cells and medium after 
exposure to zymosan. Cells were incubated in the presence of buffer alone (O), zymosan, 1 mg/ml (O), or 
zymosan plus CB, 10 ~g/ml (O). Tubes were removed at intervals during the incubation for measurement 
of lysosomal enzyme activity in incubation medium and in cells, as described in Materials and Methods. 
phosphatase or/3-galactosidase were  altered when 
these enzymes were released in the presence of CB, 
or when CB was added to the incubation medium 
containing these enzymes released from cells either 
by incubation with zymosan or by sonication (Figs. 
6, 7). 
CB interferes with energy metabolism in PMN 
by  inhibiting the  uptake  of  glucose  (13).  The 
inhibitory effect of the antibiotic on phagocytosis 
could possibly be coupled to this effect  on glucose 
metabolism. Inhibition of phagocytosis could also 
result in enhanced lysosomal enzyme release by the 
process  of "regurgitation during feeding"  if CB 
inhibited closure of the mouth of the  phagocytic 
vesicle  (2,  15). Our  data  suggest,  however,  that 
inhibition of phagocytosis and enhanced lysosomal 
enzyme release are not dependent on an effect of 
CB on glucose uptake. The concentration-response 
curves for the effects of CB on zymosan-induced 
inulin uptake and lysosomal enzyme release were 
almost  identical  in  the  presence  or  absence  of 
glucose (Fig. 3). 
The effect  of CB  on  PMN  function is not the 
result of a lethal toxic effect,  for the effects  of CB 
on PMN are reversible when cells are washed free 
of  the  antibiotic  (16);  also,  there  is  a  lack  of 
nonspecific loss of enzymes, such as the cytoplas- 
mic enzyme LDH,  from cells incubated with CB 
(1-4) (Fig. 5). 
Davies et al. (1) reported that CB stimulated the 
release of the lysosomal enzymes ~/-glucuronidase, 
~/-galactosidase,  and  acid  protease  from  rabbit 
PMN incubated in the absence of particles. How- 
ever, we (Fig. 2) as well as others (2, 4) have found 
that  CB  does  not stimulate release  of lysosomal 
enzymes by "resting" PMN. This suggests that CB 
acts by altering the mode of response of PMN to 
particles to which  they are exposed. 
A  hypothesis has been proposed  independently 
by a number of investigators to explain the effects 
of CB on zymosan-stimulated iysosomal enzyme 
release from PMN (1, 2, 4).  In a number of cells, 
CB binds to membrane-associated microfilaments 
and  interferes  with  their  function.  It  has  been 
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ments  in  PMN  acts  as a barrier to the release of 
lysosomal  enzymes.  By  interfering  with  the  net- 
work,  CB could enhance the release of lysosomal 
enzymes.  Our  results  are not consistent  with  this 
hypbthesis.  If CB were to remove a  barrier to the 
release  of lysosomal enzymes,  then  cells preincu- 
bated  with  CB  and  exposed  to  zymosan  should 
release enzyme at a  faster rate than cells preincu- 
bated  without  CB.  This  is  not  the  case.  Cells 
exposed  to  CB  before  stimulation  by  zymosan 
release lysosomal enzymes only after a lag period, 
whereas  cells preincubated  in  the  absence  of CB 
promptly release lysosomal enzymes when exposed 
to  zymosan  (Fig.  3).  Secondly,  if the  antibiotic 
removed a  barrier  to  enzyme release,  it might  be 
expected  that  more  enzyme  would  be  lost  from 
cells in the presence of CB than in its absence. This 
also  is  not  the  case;  the total  amount  of enzyme 
lost from cells is greater when PMN are incubated 
with zymosan alone than when they are incubated 
with zymosan  plus CB (Fig. 8). 
We would like to offer the following explanation 
for the effect of CB on lysosomal enzyme release: 
When  PMN  are  exposed  to  zymosan  (in  the 
absence  of  CB),  the  particle  is  phagocytosed. 
During  the  process  of  phagocytosis,  lysosomal 
enzymes  are  released  into  the  developing  phago- 
cytic  vesicle.  A  substantial  amount  of  enzyme 
activity  enters  the  extracellular  medium  through 
the  unclosed  mouth  of the  vesicle (regurgitation 
during feeding [10]). As phagocytosis is completed, 
secretion  of  some  lysosomal  enzyme  into  the 
developed  phagocytic  vesicle continues.  This  en- 
zyme activity is rapidly  lost, either because  of its 
instability  in  the  extracellular  medium  contained 
within the vesicle or because of its degradation  by 
enzymes  such  as  neutral  protease,  contained  in 
lysosomes  and  presumably  also  secreted  into  the 
vesicle.  Under  these  conditions  of  exposure  to 
zymosan,  a  small amount of lysosomal enzyme is 
also  secreted  directly  across  the  cell  membrane. 
The  amount  of enzyme recovered from the extra- 
cellular  medium  is  less  than  the  fall  in  enzyme 
activity in the cells because  of the loss of enzyme 
activity in the phagocytic vesicle and extracellular 
medium.  When  cells  are  exposed  to  CB  (either 
before or  simultaneously  with  exposure  to zymo- 
san),  phagocytosis  is  markedly  inhibited.  Thus 
lysosomal enzyme  is  released  only across the cell 
membrane,  primarily at the  site of attachment  of 
particles to the cell (4,  17). There is no appreciable 
loss  of enzyme  activity  into  phagocytic  vesicles. 
Therefore, the amount  of enzyme recovered from 
the  extracellular  medium  more  closely  approxi- 
mates  the  amount  lost  from  cells.  According  to 
this  explanation,  it  is  not  necessary  to  postulate 
that  CB removes an  inhibitory influence of mem- 
brane-associated  microfilaments on lysosomal en- 
zyme release. We suggest that the conclusion from 
previous studies that microfilaments directly mod- 
ulate lysosomal enzyme release requires reconsid- 
eration. 
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